Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CBM588”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Not applicableNot Yet RecruitingNCT07422103
What this trial is testing

PAN-CLO-BU (PANcreas-CLOstridium-BUtyricum)

Who this might be right for
Pancreatic CancerPancreatic DiseasesGastrointestinal Symptoms+3 more
Casa di Cura Dott. Pederzoli 158
Early research (Phase 1)Active Not RecruitingNCT05122546
What this trial is testing

CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Papillary Renal Cell CarcinomaAdvanced Renal Cell Carcinoma+9 more
City of Hope Medical Center 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07037004
What this trial is testing

Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery

Who this might be right for
Clear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage II Renal Cell Cancer AJCC v8+2 more
City of Hope Medical Center 62
Testing effectiveness (Phase 2)WithdrawnNCT01077245
What this trial is testing

Safety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile Infections

Who this might be right for
Clostridium Difficile Infection
Osel, Inc.
Early research (Phase 1)Study completedNCT03829111
What this trial is testing

CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer

Who this might be right for
Advanced Renal Cell CarcinomaClear Cell Renal Cell CarcinomaMetastatic Renal Cell Carcinoma+3 more
City of Hope Medical Center 30
Early research (Phase 1)Active Not RecruitingNCT03922035
What this trial is testing

CBM588 in Improving Clinical Outcomes in Patients Who Have Undergone Donor Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
City of Hope Medical Center 36
Early research (Phase 1)Looking for participantsNCT06399419
What this trial is testing

CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer

Who this might be right for
Advanced Clear Cell Renal Cell CarcinomaAdvanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell Carcinoma+5 more
Osel, Inc. 28
Not applicableStudy completedNCT06676514
What this trial is testing

Study to Evaluate the Treatment Benefits of Probiotic Clostridium Butyricum CBM588® for IBS-D

Who this might be right for
IBS-D (Diarrhea-predominant)
Liaquat University of Medical & Health Sciences 405
Not applicableStudy completedNCT06852274
What this trial is testing

Clostridium Butyricum CBM588® vs. Rifaximin for Symptomatic Uncomplicated Diverticular Disease (SUDD): A Real-World Retrospective Study

Who this might be right for
Diverticular DiseasesGastro-Intestinal Disorder
Dr. Amjad Khan 70
Not applicableEnrolling By InvitationNCT06855355
What this trial is testing

CBM588 Reduces Colorectal Polyp Recurrence

Who this might be right for
Colorectal Polyp
Kaohsiung Medical University 500